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The National Heart Lung and Blood Institute (NHBLI)
recommends the use of inhaled anti-inﬂammatory 
medications (inhaled corticosteroids, inhaled cromolyn,
or inhaled nedocromil) for patients with persistent
asthma. OBJECTIVE: The purpose of the study was to
investigate the effect of inhaled anti-inﬂammatory med-
ications on subsequent inpatient hospital events, while
controlling for demographic and resources use variables.
METHODS: Medication and medical service records
were extracted for Texas Medicaid patients who were
classiﬁed as having persistent asthma based on criteria set
by the National Committee for Quality Assurance
(NCQA). A historical cohort design was used. An
asthma-related hospitalization (with no previous hospi-
talization for a least six months before) served as the
index event. Patients were then followed until a subse-
quent hospitalization occurred or until one-year past their
index event. Outcomes of patient who had at least 1 pre-
scription for an inhaled anti-inﬂammatory within 100
days of their index hospitalization were compared with
patients who did not have any records of these types of
medications for one year following their index event.
Logistic regression was used to compare the two groups
while controlling for other factors. RESULTS: There were
728 persistent asthma patients in the exposed group
(those with inhaled anti-inﬂammatory use within 100
days) compared to 981 without exposure to these types
of medications. Controlling for age, gender, ethnicity, and
previous resource use, those in the exposed group had 32
percent reduction in the risk of a subsequent hospitaliza-
tion in the year following their index hospitalization (RR
= 0.681, p = 0.017, 95% CI 0.497–0.933). CONCLU-
SIONS: For patients categorized as persistent asthmatics,
less than half received anti-inﬂammatory medications (as
recommended by the NHBLI) within the ﬁrst 100 days
after their index asthma-related hospitalization. Patients 
who did receive these medications had a lower risk of a
subsequent asthma-related hospitalization for the next
year.
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OBJECTIVES: The epidemiology of acute sinusitis 
and acute exacerbation of chronic sinusitis (AECS) is still
unknown in Germany. This study aims to make an 
estimate of the prevalence of acute sinusitis and AECS in
Germany. METHODS: A representative sample of 63
GPs and 40 ear, nose and throat specialists have been
asked to document all patients older than 16 years with
acute sinusitis or AECS appearing in their practice over 
a period of one week (during the time frame from 
February 2nd to April 1st, 2001). Afterwards, an expan-
sion for Germany has been calculated/estimated.
RESULTS: Overall, 2,250 patients suffering from acute
sinusitis or AECS has been documented in 8 weeks. One
thousand one hundred eighty-seven patients visited a GP
and 1,063 patients visited an ear, nose and throat 
specialist. Eighty percent of patients suffered from 
acute sinusitis, whilst 20% had an acute exacerbation of
chronic sinusitis. On the average, each GP treated 19
sinusitis patients per week, i.e. 9% of total patients 
visiting the practice. An ear, nose and throat specialist
treated 27 patients per week, which means 11% of his
total patients. Based on the assumption that 67.5 million
people older than 16 years live in Germany (2001), there
are approximately 1.215.000 sinusitis patients per week,
i.e. 1.8% of German population having a sinusitis and
seeing their GP in an average winter week. CONCLU-
SIONS: Assuming at least 20 weeks of wintertime 
(from November to March), there are approximately
24.300.000 sinusitis patients in Germany within this time
frame. This means hardly one third of German popula-
tion. When interpreting this result it is important to take
into account that sinusitis is a disease with repeating 
exacerbations.
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OBJECTIVES: To assess the severity of obstructive
airways disease using a postal questionnaire and to
examine correlations between healthcare utilisation/cost
and disease severity. METHOD: A postal survey was 
